IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity

Melanie Walter(The University of Sydney), Ezio Bonifacio(Technische Universität Dresden), Michael Hummel(Charité - Universitätsmedizin Berlin), Bryan J. Barratt(AstraZeneca (United Kingdom)), E. Keller(University of Zurich), Anette‐Gabriele Ziegler(Helmholtz Zentrum München), Karin M. Ferber(München Klinik Schwabing), John A. Todd(University of Oxford), E. D. Albert, Matthias Conrad(München Klinik Schwabing)
Diabetologia
May 1, 2003
10.1007/s00125-003-1082-z
Cited by 108

Related Papers

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
|Nature|2007|9.7k
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
|Nature Genetics|2007|1.5k
Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters
|Cell|2016|1.2k
Finite Unitary Reflection Groups
|Canadian Journal of Mathematics|1954|1.1k